Literature DB >> 20679834

Supermicrosurgery in peroneal and soleus perforator-based free flap coverage of foot defects caused by occlusive vascular diseases.

Chang Yeon Kim1, Shenthilkumar Naidu, Youn Hwan Kim.   

Abstract

BACKGROUND: Limb salvage rates for lower limbs have improved tremendously for trauma and tumor victims. The optimal solution for coverage of defects caused by ischemic limbs does not exist. The authors believe the use of supermicrosurgery and perforator flap surgery might add a further tool useful to the reconstructive surgeon.
METHODS: After excisional débridement of the wound, under loupe magnification, branches of the terminal foot vessels were sought. Once identified and deemed suitable, the thin peroneal flaps were isolated based on perforator vessels. The flaps raised were either peroneal perforator-based or soleus perforator-based flaps. Microanastomosis was performed at the perforator level with 10-0 or 11-0 Ethilon sutures, and the flap was inset. The donor site was closed primarily.
RESULTS: A total of 18 such flaps were raised in 17 patients with 15 septocutaneous and three musculocutaneous perforators. Sixteen peroneal perforator-based flaps and two soleus perforator-based flaps were used. There was one major (flap loss) and two minor (wound dehiscence) complications. The rest of the patients healed well, with no recurrence at a mean follow-up of 8.3 months.
CONCLUSIONS: Limb salvage in ischemic limbs is now possible with supermicrosurgery and perforator flaps. This method allows contour resurfacing, avoids bulky tissue, is fast, and can be performed under regional anesthesia.

Entities:  

Mesh:

Year:  2010        PMID: 20679834     DOI: 10.1097/PRS.0b013e3181df64c2

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  1 in total

1.  Validity of the use of a subfascial vessel as the recipient vessel in a second free flap transfer: A retrospective clinical review.

Authors:  Sang Won Seo; Kyu Nam Kim; Won Ha; Chi Sun Yoon
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.